文献速递淋巴瘤

慢性淋巴细胞白血病的民族与地理多样性

Ethnic and geographic diversity of chronic lymphocytic leukaemia.
PubMed 文献 · Leukemia · 2020-10-19

不同人群与古人类(如尼安德特人)的混合差异可能解释发病率不同,但非洲黑人真实发病率未知,无法判断易感性获得或丢失方向。

要点

  • 发病率差异可能源于遗传而非环境,与古人类混合差异有关。
  • 非洲黑人真实年龄调整发病率未知,易感性演化方向无法确定。

研究设计与样本

  • 综述,未报告系统检索范围与样本量。

主要发现

  • 上述人群均源于非洲黑人共同祖先,但与尼安德特人、丹尼索瓦人和直立人等古人类的混合不同,可能解释CLL发病率差异。
  • 不同人群间CLL的临床实验室和分子协变量存在差异。
  • 研究的其他B细胞淋巴瘤及T和NK细胞癌症在人群间发病率也不同。

临床怎么用

  • 临床解读CLL发病率差异时应考虑遗传背景与古人类混合因素,而非仅环境暴露。

局限性

  • 非洲黑人真实年龄调整发病率未知,无法判断现代欧洲人获得易感性还是其他人群失去易感性或产生抵抗。
  • 综述未报告系统检索策略与纳入研究数量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

East Asians, Asian Indians and Amerindians have a five to ten-fold lower age-adjusted incidence rate (AAIR) of chronic lymphocytic leukaemia (CLL) compared with persons of predominately European descent. The data we review suggest a genetic rather than environmental basis for this discordance. All these populations arose from a common African Black ancestor but different clades have different admixture with archaic hominins including Neanderthals, Denisovans and Homo erectus, which may explain different CLL incidences. There are also some differences in clinical laboratory and molecular co-variates of CLL between these populations. Because the true age-adjusted incidence rate in African Blacks is unknown it is not possible to determine whether modern Europeans acquired susceptibility to CLL or the other populations lost susceptibility and/or developed resistance to developing CLL. We also found other B-cell lymphomas and T- and NK-cell cancers had different incidences in the populations we studied. These data provide clues to determining the cause(s) of CLL.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Yang S, Varghese AM, Sood N, et al. Ethnic and geographic diversity of chronic lymphocytic leukaemia. Leukemia. 2020. PMID: 33077870. doi:10.1038/s41375-020-01057-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。